Free Trial

Merck KGaA (OTCMKTS:MKGAF) Shares Gap Down - Here's Why

Merck KGaA logo with Medical background

Key Points

  • Merck KGaA shares opened at $124.67, down from a previous close of $130.26, reflecting a notable gap down in price.
  • The company's market capitalization stands at $16.72 billion, with a price-to-earnings ratio of 19.76 and a debt-to-equity ratio of 0.27.
  • Merck KGaA operates across three segments: Life Science, Healthcare, and Electronics, providing a range of products and services for various industries.
  • Five stocks we like better than Merck KGaA.

Shares of Merck KGaA (OTCMKTS:MKGAF - Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $130.26, but opened at $124.67. Merck KGaA shares last traded at $129.48, with a volume of 160 shares.

Merck KGaA Price Performance

The stock's 50-day moving average price is $129.70 and its 200-day moving average price is $133.92. The company has a market capitalization of $16.72 billion, a price-to-earnings ratio of 19.76 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.